For centuries, ashwagandha (Withania somnifera) has been a cornerstone of Ayurvedic medicine, prized for its ability to reduce stress, boost energy, and promote overall wellness. But recent scientific research is uncovering something far more remarkable: this ancient herb may actually help kill cancer cells.
A growing body of peer-reviewed studies published in 2025 and 2026 demonstrates that ashwagandha and its active compounds—particularly withanolides and withaferin A—exhibit significant anticancer activity across multiple cancer types. Here’s what the latest research reveals.
What the Studies Show
Lung and Breast Cancer
A 2025 study published in the Indian Journal of Natural Products and Resources found that a chemically standardized extract of ashwagandha successfully reduced the viability of breast cancer (MCF-7) and lung cancer (A549) cell lines. The extract worked through two key mechanisms: promoting apoptosis (programmed cell death) and arresting the cell cycle in the G0/G1 phase, effectively stopping cancer cells from dividing and spreading.
Liver Cancer
A 2026 study published in PMC investigated ashwagandha aqueous extract against hepatocellular carcinoma (liver cancer). The results were striking: the extract significantly reduced liver cancer cell viability in a concentration-dependent manner. Perhaps most importantly, ashwagandha was shown to target cancer stem cells—the cells often responsible for therapy resistance and cancer recurrence—by modulating the Hedgehog signaling pathway.
Colon Cancer
Research on withaferin-A, a bioactive compound derived from ashwagandha leaves, demonstrated inhibition of colon cancer cell growth by blocking STAT3 transcriptional activity—a pathway implicated in cancer development and progression. In animal models, treatment with withaferin-A significantly reduced tumor volume and weight compared to untreated controls.
Non-Small Cell Lung Carcinoma (NSCLC)
A 2026 study in the Journal of Ethnopharmacology validated Withanolide B as a potent modulator of the PI3K/AKT survival signaling pathway in NSCLC. The compound induced ROS accumulation, mitochondrial dysfunction, and apoptosis in cancer cells. Crucially, it exhibited reduced toxicity toward normal lung epithelial cells, suggesting cancer-selective activity.
Neuroblastoma
A 2025 study explored ashwagandha root fractions against human neuroblastoma cells—an aggressive pediatric cancer. The results demonstrated promising anti-metastatic activity, with certain fractions showing significant anti-invasive and anti-adhesive effects.
How Does Ashwagandha Kill Cancer Cells?
The research points to several distinct mechanisms:
- Inducing Apoptosis – Ashwagandha triggers programmed cell death in cancer cells through caspase activation and disruption of the Bcl-2/Bax balance.
- Cell Cycle Arrest – The herb stops cancer cells from dividing by interfering with cyclin expression and halting progression through the cell cycle.
- Inhibiting Metastasis – Ashwagandha compounds have demonstrated the ability to block cancer cell invasion and adhesion, potentially preventing spread.
- Targeting Cancer Stem Cells – Perhaps most significantly, ashwagandha appears to target the very cells responsible for treatment resistance and recurrence.
- Synergistic Effects with Chemotherapy – A 2025 study found that ashwagandha ethanol extract demonstrated a synergistic effect when combined with doxorubicin, a common chemotherapy drug, in breast cancer treatment.
A Note of Caution
While these findings are incredibly promising, it’s important to keep several things in mind:
- Most studies are in vitro (test tubes and cell cultures) or early-stage animal models. More research in humans is needed.
- A Phase 1/2 trial of oral ashwagandha combined with liposomal doxorubicin is currently underway for recurrent ovarian cancer—a step toward clinical application.
- Always consult with your oncologist before adding any supplement to your regimen.
- Quality and standardization of ashwagandha extracts vary widely. Not all products are created equal.
The Bottom Line
The emerging research on ashwagandha’s anticancer properties is genuinely exciting. From lung and breast cancer to liver, colon, and neuroblastoma, the evidence suggests that this ancient herb contains potent bioactive compounds capable of inducing cancer cell death, halting tumor growth, and even enhancing the effectiveness of conventional chemotherapy.
As science continues to unlock the secrets of traditional medicines, ashwagandha stands out as a promising candidate for integrative cancer therapy. While we await more human clinical trials, one thing is clear: this “Indian ginseng” is much more than a stress-relief supplement—it may well be a powerful ally in the fight against cancer.
Get my book “How to Naturally Remove Cancer from the Body” on my website or Amazon.com.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you are undergoing cancer treatment.
